Clinical trial
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
NCT04519164 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- September 17, 2025
- Enrollment
- 79 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertension, metabolic syndrome, overweight and obesity